CVE-2024-2259: Meddiff Technologies Instarispacs

Medium severity, CVSS 6.4. EPSS: 0.5% chance of exploitation in the next 30 days.

This vulnerability exists in InstaRISPACS software due to insufficient validation of user supplied input for the loginTo parameter in user login module of the web interface of the application. A remote attacker could exploit this vulnerability by sending a specially crafted input to the vulnerable parameter to perform reflected Cross Site Scripting (XSS) attacks on the targeted system.

Affected products

• Meddiff Technologies Instarispacs: version 3.0.0 only

Published 2024-08-13. Last modified 2026-06-17.